BEVERLIE HOUSER: Open Payments
NPI 1003204660 · FORT GRATIOT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 9 payments from 6 companies in 2025. Trend: 2023 $127 · 2024 $199 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Novo Nordisk Inc | 2 | $31 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: REXULTI, XIFAXAN, Wegovy, NUPLAZID, SPRAVATO, Auvelity.
Industry payments across MI — which companies pay providers there.
